De‐escalating medical therapy in Crohn’s disease patients who are in deep remission: A RAND appropriateness panel
GastroHep · 2019
DOI: 10.1002/ygh2.337 ↗Kurz gefasst
Fachartikel in der Zeitschrift GastroHep, 2019. Verfasst von Miles P. Sparrow und 15 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sparrow, M. P., Melmed, G. Y., Devlin, S., Kozuch, P., Raffals, L., Jr, E. V. L., Rubin, D. T., Spiegel, B., Baidoo, L., Bressler, B., Cheifetz, A., Irving, P., Jones, J., Kaplan, G. G., Velayos, F., & Siegel, C. A. (2019). De‐escalating medical therapy in Crohn’s disease patients who are in deep remission: A RAND appropriateness panel. GastroHep. https://doi.org/10.1002/ygh2.337
Vancouver
Sparrow MP, Melmed GY, Devlin S, Kozuch P, Raffals L, Jr EVL, et al. De‐escalating medical therapy in Crohn’s disease patients who are in deep remission: A RAND appropriateness panel. GastroHep. 2019. doi:10.1002/ygh2.337
BibTeX
@article{Sparrow2019,
author = {Sparrow, Miles P. and Melmed, Gil Y. and Devlin, Shane and Kozuch, Patricia and Raffals, Laura and Jr, Edward V. Loftus and Rubin, David T. and Spiegel, Brennan and Baidoo, Leonard and Bressler, Brian and Cheifetz, Adam and Irving, Peter and Jones, Jennifer and Kaplan, Gilaad G. and Velayos, Fernando and Siegel, Corey A.},
title = {De‐escalating medical therapy in Crohn’s disease patients who are in deep remission: A RAND appropriateness panel},
journal = {GastroHep},
year = {2019},
doi = {10.1002/ygh2.337}
}
EUVIMED